ASCENT INDUSTRIES CORP Stock Canadian Securities Exchange
Stocks
LUFF
CA04365B1067
Pharmaceuticals
OTC Markets Traded|
Delayed
Canadian Securities Exchange
20:05:12 04/10/2021 +03
|
5-day change | 1st Jan Change | ||
| 0.0200 CAD | -20.00% |
|
+25.00% | +66.67% |
| Market Cap | 4.58M 3.25M 2.84M 2.67M 2.44M 311M 4.58M 32.06M 12.37M 159M 12.21M 11.95M 512M | P/E 2024 |
-1.85x | P/E 2025 | -3.69x |
|---|---|---|---|---|---|
| Enterprise Value | 6.08M 4.32M 3.78M 3.55M 3.24M 413M 6.08M 42.61M 16.44M 211M 16.23M 15.88M 680M | EV / Sales 2024 |
0.67x | EV / Sales 2025 | 0.89x |
| Free-Float |
85.23% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -20.00% |
| Manager | Title | Age | Since |
|---|---|---|---|
Philip Campbell
CEO | Chief Executive Officer | - | 15/05/2020 |
Jason Vandenberg
DFI | Director of Finance/CFO | 49 | 18/01/2022 |
Aron Tegenfeldt
PRN | Corporate Officer/Principal | - | 01/08/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Philip Campbell
BRD | Director/Board Member | - | 15/05/2020 |
Drew Malcolm
BRD | Director/Board Member | - | 24/06/2020 |
Herb Dhaliwal
CHM | Chairman | 73 | 23/04/2026 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -20.00% | +25.00% | - | - | 3.26M | |
| +0.45% | +1.10% | -12.24% | -3.06% | 13.61B | |
| 0.00% | +0.38% | -31.99% | -55.53% | 4.85B | |
| +0.33% | -1.55% | -4.35% | -5.10% | 4.35B | |
| -0.06% | +1.30% | -5.35% | -30.85% | 3.89B | |
| -0.88% | -2.64% | -2.83% | -4.48% | 3.44B | |
| -0.28% | +1.36% | -20.30% | +5.09% | 3.5B | |
| -0.85% | -0.43% | -10.75% | +3.49% | 3.14B | |
| 0.00% | +1.03% | -20.89% | -16.22% | 2.29B | |
| +0.20% | +3.05% | -25.76% | -20.97% | 1.68B | |
| Average | -2.11% | +1.12% | -14.94% | -14.18% | 4.53B | |
| Weighted average by Cap. | +0.02% | +1.01% | -13.92% | -12.56% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 9.92M 7.05M 6.16M 5.79M 5.29M 674M 9.93M 69.54M 26.83M 344M 26.49M 25.91M 1.11B | 12.12M 8.62M 7.53M 7.08M 6.46M 824M 12.13M 84.96M 32.78M 421M 32.37M 31.66M 1.36B |
| Net income | -2.77M -1.97M -1.72M -1.62M -1.48M -188M -2.77M -19.43M -7.5M -96.24M -7.4M -7.24M -310M | -1.84M -1.31M -1.14M -1.08M -981K -125M -1.84M -12.9M -4.98M -63.91M -4.92M -4.81M -206M |
| Net Debt | 1.37M 977K 854K 803K 733K 93.43M 1.38M 9.63M 3.72M 47.71M 3.67M 3.59M 154M | 1.51M 1.07M 935K 879K 802K 102M 1.51M 10.55M 4.07M 52.25M 4.02M 3.93M 168M |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- HERB Stock
- LUFF Stock
Select your edition
All financial news and data tailored to specific country editions
